中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma

文献类型:期刊论文

刊名CHINESE MEDICAL JOURNAL
出版日期2011
卷号124
关键词GENE-THERAPY INTERFERON-ALPHA IN-VIVO CANCER SUNITINIB ONYX-015 MODEL TRIAL oncolysis adenovirus gemcitabine renal cell carcinoma
ISSN号0366-6999
其他题名E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma
英文摘要Background Our previous studies have demonstrated potent oncolysis efficacy of the E1A, E1B double-restricted replication-competent oncolytic adenovirus AxdAdB-3 for treatment of bladder cancer. Here, we reported the feasibility and efficacy of AxdAdB-3 alone, or in combination with gemcitabine for treating renal cell carcinoma.
资助项目[Qianjiang Program of Zhejiang Province]
语种英语
CSCD记录号CSCD:4428515
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/49843]  
专题中国科学院合肥物质科学研究院
推荐引用方式
GB/T 7714
. E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma[J]. CHINESE MEDICAL JOURNAL,2011,124.
APA (2011).E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma.CHINESE MEDICAL JOURNAL,124.
MLA "E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma".CHINESE MEDICAL JOURNAL 124(2011).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。